Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.
Identifieur interne : 000941 ( PubMed/Curation ); précédent : 000940; suivant : 000942Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.
Auteurs : Edwin J. Asturias [États-Unis] ; Melinda Wharton [États-Unis] ; Robert Pless [Canada] ; Noni E. Macdonald [Canada] ; Robert T. Chen [États-Unis] ; Nicholas Andrews [Royaume-Uni] ; David Salisbury [Royaume-Uni] ; Alexander N. Dodoo [Ghana] ; Kenneth Hartigan-Go [Philippines] ; Patrick L F. Zuber [Suisse]Source :
- Vaccine [ 1873-2518 ] ; 2016.
Abstract
In 1999, the Global Advisory Committee on Vaccine Safety (GACVS) was established by the World Health Organization (WHO) to provide independent scientific advice on issues relating to the safety of vaccines and immunization. Fifteen years onward, we conducted a multi-faceted review to evaluate the impact, reach and challenges facing GACVS, including the role GACVS plays in informing global, regional and WHO member state vaccine policy. The methods included measures of organizational structure, citation impact, themes approached, and a discussion by previous and current members to evaluate past, present and future challenges. Given the increasing range of data sources and the deployment of many new vaccines, the Committee is facing the complex task of identifying the best available evidence for recommendations on vaccine safety. To help meet the increased demand for public transparency in decision making, GACVS-structured methodology for evidence-based decisions is evolving. GACVS also promotes best practices and capacity building for timely and accurate risk assessment; risk communications; outreach to help countries maintain and, if needed, rebuild public trust in vaccines; and advocacy for bridging the major gaps in vaccine safety capacity globally.
DOI: 10.1016/j.vaccine.2016.05.018
PubMed: 27195758
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000942
Links to Exploration step
pubmed:27195758Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.</title><author><name sortKey="Asturias, Edwin J" sort="Asturias, Edwin J" uniqKey="Asturias E" first="Edwin J" last="Asturias">Edwin J. Asturias</name><affiliation wicri:level="1"><nlm:affiliation>Center for Global Health, Colorado School of Public Health, Aurora, CO, USA; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: edwin.asturias@ucdenver.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Global Health, Colorado School of Public Health, Aurora, CO, USA; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO</wicri:regionArea></affiliation></author><author><name sortKey="Wharton, Melinda" sort="Wharton, Melinda" uniqKey="Wharton M" first="Melinda" last="Wharton">Melinda Wharton</name><affiliation wicri:level="1"><nlm:affiliation>National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea></affiliation></author><author><name sortKey="Pless, Robert" sort="Pless, Robert" uniqKey="Pless R" first="Robert" last="Pless">Robert Pless</name><affiliation wicri:level="1"><nlm:affiliation>Communicable Disease Surveillance, Public Health Agency of Canada, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Communicable Disease Surveillance, Public Health Agency of Canada</wicri:regionArea></affiliation></author><author><name sortKey="Macdonald, Noni E" sort="Macdonald, Noni E" uniqKey="Macdonald N" first="Noni E" last="Macdonald">Noni E. Macdonald</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, Dalhousie University, Halifax, NS, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pediatrics, Dalhousie University, Halifax, NS</wicri:regionArea></affiliation></author><author><name sortKey="Chen, Robert T" sort="Chen, Robert T" uniqKey="Chen R" first="Robert T" last="Chen">Robert T. Chen</name><affiliation wicri:level="1"><nlm:affiliation>National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea></affiliation></author><author><name sortKey="Andrews, Nicholas" sort="Andrews, Nicholas" uniqKey="Andrews N" first="Nicholas" last="Andrews">Nicholas Andrews</name><affiliation wicri:level="1"><nlm:affiliation>Statistics, Modelling and Economics Department, Public Health England, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Statistics, Modelling and Economics Department, Public Health England, London</wicri:regionArea></affiliation></author><author><name sortKey="Salisbury, David" sort="Salisbury, David" uniqKey="Salisbury D" first="David" last="Salisbury">David Salisbury</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Global Health Security, Chatham House, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Centre for Global Health Security, Chatham House, London</wicri:regionArea></affiliation></author><author><name sortKey="Dodoo, Alexander N" sort="Dodoo, Alexander N" uniqKey="Dodoo A" first="Alexander N" last="Dodoo">Alexander N. Dodoo</name><affiliation wicri:level="1"><nlm:affiliation>WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, School of Medicine and Dentistry, University of Ghana Medical School, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, School of Medicine and Dentistry, University of Ghana Medical School</wicri:regionArea></affiliation></author><author><name sortKey="Hartigan Go, Kenneth" sort="Hartigan Go, Kenneth" uniqKey="Hartigan Go K" first="Kenneth" last="Hartigan-Go">Kenneth Hartigan-Go</name><affiliation wicri:level="1"><nlm:affiliation>Center for Development Management, Asian Institute of Management, Philippines.</nlm:affiliation><country xml:lang="fr">Philippines</country><wicri:regionArea>Center for Development Management, Asian Institute of Management</wicri:regionArea></affiliation></author><author><name sortKey="Zuber, Patrick L F" sort="Zuber, Patrick L F" uniqKey="Zuber P" first="Patrick L F" last="Zuber">Patrick L F. Zuber</name><affiliation wicri:level="1"><nlm:affiliation>Department of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Essential Medicines and Health Products, World Health Organization, Geneva</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27195758</idno><idno type="pmid">27195758</idno><idno type="doi">10.1016/j.vaccine.2016.05.018</idno><idno type="wicri:Area/PubMed/Corpus">000942</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000942</idno><idno type="wicri:Area/PubMed/Curation">000941</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000941</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.</title><author><name sortKey="Asturias, Edwin J" sort="Asturias, Edwin J" uniqKey="Asturias E" first="Edwin J" last="Asturias">Edwin J. Asturias</name><affiliation wicri:level="1"><nlm:affiliation>Center for Global Health, Colorado School of Public Health, Aurora, CO, USA; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: edwin.asturias@ucdenver.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Global Health, Colorado School of Public Health, Aurora, CO, USA; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO</wicri:regionArea></affiliation></author><author><name sortKey="Wharton, Melinda" sort="Wharton, Melinda" uniqKey="Wharton M" first="Melinda" last="Wharton">Melinda Wharton</name><affiliation wicri:level="1"><nlm:affiliation>National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea></affiliation></author><author><name sortKey="Pless, Robert" sort="Pless, Robert" uniqKey="Pless R" first="Robert" last="Pless">Robert Pless</name><affiliation wicri:level="1"><nlm:affiliation>Communicable Disease Surveillance, Public Health Agency of Canada, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Communicable Disease Surveillance, Public Health Agency of Canada</wicri:regionArea></affiliation></author><author><name sortKey="Macdonald, Noni E" sort="Macdonald, Noni E" uniqKey="Macdonald N" first="Noni E" last="Macdonald">Noni E. Macdonald</name><affiliation wicri:level="1"><nlm:affiliation>Department of Pediatrics, Dalhousie University, Halifax, NS, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pediatrics, Dalhousie University, Halifax, NS</wicri:regionArea></affiliation></author><author><name sortKey="Chen, Robert T" sort="Chen, Robert T" uniqKey="Chen R" first="Robert T" last="Chen">Robert T. Chen</name><affiliation wicri:level="1"><nlm:affiliation>National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA</wicri:regionArea></affiliation></author><author><name sortKey="Andrews, Nicholas" sort="Andrews, Nicholas" uniqKey="Andrews N" first="Nicholas" last="Andrews">Nicholas Andrews</name><affiliation wicri:level="1"><nlm:affiliation>Statistics, Modelling and Economics Department, Public Health England, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Statistics, Modelling and Economics Department, Public Health England, London</wicri:regionArea></affiliation></author><author><name sortKey="Salisbury, David" sort="Salisbury, David" uniqKey="Salisbury D" first="David" last="Salisbury">David Salisbury</name><affiliation wicri:level="1"><nlm:affiliation>Centre for Global Health Security, Chatham House, London, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Centre for Global Health Security, Chatham House, London</wicri:regionArea></affiliation></author><author><name sortKey="Dodoo, Alexander N" sort="Dodoo, Alexander N" uniqKey="Dodoo A" first="Alexander N" last="Dodoo">Alexander N. Dodoo</name><affiliation wicri:level="1"><nlm:affiliation>WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, School of Medicine and Dentistry, University of Ghana Medical School, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, School of Medicine and Dentistry, University of Ghana Medical School</wicri:regionArea></affiliation></author><author><name sortKey="Hartigan Go, Kenneth" sort="Hartigan Go, Kenneth" uniqKey="Hartigan Go K" first="Kenneth" last="Hartigan-Go">Kenneth Hartigan-Go</name><affiliation wicri:level="1"><nlm:affiliation>Center for Development Management, Asian Institute of Management, Philippines.</nlm:affiliation><country xml:lang="fr">Philippines</country><wicri:regionArea>Center for Development Management, Asian Institute of Management</wicri:regionArea></affiliation></author><author><name sortKey="Zuber, Patrick L F" sort="Zuber, Patrick L F" uniqKey="Zuber P" first="Patrick L F" last="Zuber">Patrick L F. Zuber</name><affiliation wicri:level="1"><nlm:affiliation>Department of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland.</nlm:affiliation><country xml:lang="fr">Suisse</country><wicri:regionArea>Department of Essential Medicines and Health Products, World Health Organization, Geneva</wicri:regionArea></affiliation></author></analytic><series><title level="j">Vaccine</title><idno type="eISSN">1873-2518</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In 1999, the Global Advisory Committee on Vaccine Safety (GACVS) was established by the World Health Organization (WHO) to provide independent scientific advice on issues relating to the safety of vaccines and immunization. Fifteen years onward, we conducted a multi-faceted review to evaluate the impact, reach and challenges facing GACVS, including the role GACVS plays in informing global, regional and WHO member state vaccine policy. The methods included measures of organizational structure, citation impact, themes approached, and a discussion by previous and current members to evaluate past, present and future challenges. Given the increasing range of data sources and the deployment of many new vaccines, the Committee is facing the complex task of identifying the best available evidence for recommendations on vaccine safety. To help meet the increased demand for public transparency in decision making, GACVS-structured methodology for evidence-based decisions is evolving. GACVS also promotes best practices and capacity building for timely and accurate risk assessment; risk communications; outreach to help countries maintain and, if needed, rebuild public trust in vaccines; and advocacy for bridging the major gaps in vaccine safety capacity globally.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">27195758</PMID><DateCreated><Year>2016</Year><Month>06</Month><Day>13</Day></DateCreated><DateRevised><Year>2017</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>34</Volume><Issue>29</Issue><PubDate><Year>2016</Year><Month>Jun</Month><Day>17</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.</ArticleTitle><Pagination><MedlinePgn>3342-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2016.05.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(16)30301-2</ELocationID><Abstract><AbstractText>In 1999, the Global Advisory Committee on Vaccine Safety (GACVS) was established by the World Health Organization (WHO) to provide independent scientific advice on issues relating to the safety of vaccines and immunization. Fifteen years onward, we conducted a multi-faceted review to evaluate the impact, reach and challenges facing GACVS, including the role GACVS plays in informing global, regional and WHO member state vaccine policy. The methods included measures of organizational structure, citation impact, themes approached, and a discussion by previous and current members to evaluate past, present and future challenges. Given the increasing range of data sources and the deployment of many new vaccines, the Committee is facing the complex task of identifying the best available evidence for recommendations on vaccine safety. To help meet the increased demand for public transparency in decision making, GACVS-structured methodology for evidence-based decisions is evolving. GACVS also promotes best practices and capacity building for timely and accurate risk assessment; risk communications; outreach to help countries maintain and, if needed, rebuild public trust in vaccines; and advocacy for bridging the major gaps in vaccine safety capacity globally.</AbstractText><CopyrightInformation>Copyright © 2016 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Asturias</LastName><ForeName>Edwin J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Center for Global Health, Colorado School of Public Health, Aurora, CO, USA; Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: edwin.asturias@ucdenver.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wharton</LastName><ForeName>Melinda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pless</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Communicable Disease Surveillance, Public Health Agency of Canada, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacDonald</LastName><ForeName>Noni E</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Dalhousie University, Halifax, NS, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Robert T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrews</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Statistics, Modelling and Economics Department, Public Health England, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salisbury</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Global Health Security, Chatham House, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dodoo</LastName><ForeName>Alexander N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, School of Medicine and Dentistry, University of Ghana Medical School, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartigan-Go</LastName><ForeName>Kenneth</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for Development Management, Asian Institute of Management, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuber</LastName><ForeName>Patrick L F</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Department of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CC999999</GrantID><Agency>Intramural CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>05</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Virol. 2010 Jun;84(12):6033-40</RefSource><PMID Version="1">20375174</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2006 Feb 15;42(4):548-58</RefSource><PMID Version="1">16421800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Rev Vaccines. 2009 Jun;8(6):705-16</RefSource><PMID Version="1">19485752</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2001 Feb 22;344(8):564-72</RefSource><PMID Version="1">11207352</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2008 Dec 9;26(52):6950-5</RefSource><PMID Version="1">18951940</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Semin Pediatr Infect Dis. 2003 Jul;14(3):233-9</RefSource><PMID Version="1">12913836</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Euro Surveill. 2005 Jan 13;10(1):E050113.2</RefSource><PMID Version="1">16556944</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2005 Sep 1;192 Suppl 1:S36-43</RefSource><PMID Version="1">16088803</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatrics. 1995 Mar;95(3):414-8</RefSource><PMID Version="1">7862483</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2001 Mar 21;19(17-19):2446-56</RefSource><PMID Version="1">11257376</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2012 May 30;30 Suppl 2:B46-51</RefSource><PMID Version="1">22230584</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2014 Nov 20;32(49):6649-54</RefSource><PMID Version="1">25280436</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Value Health. 2011 Jul-Aug;14 (5):768-76</RefSource><PMID Version="1">21839417</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Hum Vaccin. 2011 Feb;7(2):269-71</RefSource><PMID Version="1">21307654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Public Health. 2004 Nov;94(11):1926-31</RefSource><PMID Version="1">15514229</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2014 Apr 17;32(19):2150-9</RefSource><PMID Version="1">24598724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2000;78(2):170-7</RefSource><PMID Version="1">10743281</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>AIDS. 2001 Jan 5;15(1):55-60</RefSource><PMID Version="1">11192868</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 1999 Oct 29;17 Suppl 3:S41-6</RefSource><PMID Version="1">10559533</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2006 Mar 15;193(6):898; author reply 898-9</RefSource><PMID Version="1">16479526</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatrics. 1999 Oct;104(4 Pt 1):942-50</RefSource><PMID Version="1">10506239</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Drug Saf. 2008;31(5):389-98</RefSource><PMID Version="1">18422379</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2013 Oct 17;31(44):5041-6</RefSource><PMID Version="1">24021304</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2012 Dec 17;31(1):12-9</RefSource><PMID Version="1">22391401</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2011 Oct 6;29(43):7559-71</RefSource><PMID Version="1">21821086</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2015 Nov 27;33(48):6902-7</RefSource><PMID Version="1">25617790</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2013 Apr 18;31 Suppl 2:B108-14</RefSource><PMID Version="1">23598471</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Expert Rev Vaccines. 2015 Jan;14(1):99-117</RefSource><PMID Version="1">25373435</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Wkly Epidemiol Rec. 2007 May 25;82(21):193-6</RefSource><PMID Version="1">17526121</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 1999 Jul 7;282(1):47-53</RefSource><PMID Version="1">10404911</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2015 Jan 1;33(1):52-61</RefSource><PMID Version="1">24300593</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2015 Jan 1;33(1):187-92</RefSource><PMID Version="1">25444798</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2012 Jul 27;30(35):5229-34</RefSource><PMID Version="1">22709955</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>MMWR Morb Mortal Wkly Rep. 2015 Feb 20;64(6):153-4</RefSource><PMID Version="1">25695321</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Tuberc Lung Dis. 2009 Nov;13(11):1331-44</RefSource><PMID Version="1">19861003</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2008 Feb 26;26(9):1185-94</RefSource><PMID Version="1">18243428</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pediatrics. 2014 Aug;134(2):377-9</RefSource><PMID Version="1">25086161</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2004 May 7;22(15-16):2059-63</RefSource><PMID Version="1">15121323</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Health Policy. 2013 Oct;112(3):187-96</RefSource><PMID Version="1">23664301</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Risk Saf Med. 2011;23(2):113-5</RefSource><PMID Version="1">21673419</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Global Advisory Committee on Vaccine Safety</Keyword><Keyword MajorTopicYN="N">Global public health</Keyword><Keyword MajorTopicYN="N">Immunization program</Keyword><Keyword MajorTopicYN="N">Vaccine adverse events</Keyword><Keyword MajorTopicYN="N">Vaccine policy</Keyword><Keyword MajorTopicYN="N">Vaccine safety</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>01</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>05</Month><Day>04</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>05</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27195758</ArticleId><ArticleId IdType="pmc">PMC5085263</ArticleId><ArticleId IdType="pii">S0264-410X(16)30301-2</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2016.05.018</ArticleId><ArticleId IdType="mid">HHSPA817772</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000941 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000941 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:27195758
|texte= Contributions and challenges for worldwide vaccine safety: The Global Advisory Committee on Vaccine Safety at 15 years.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:27195758" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |